Grith Hagel
Founder bij 2CUREX AB
Profiel
Grith Hagel is the founder of 2cureX ApS, where she holds the title of Head-Project Management since 2011.
She is also the founder of 2cureX AB, where she holds the title of Vice President-Innovation.
Ms. Hagel is also the founder of Noapab Holdings A..
Ms. Hagel's former jobs include being a Principal at Novo Nordisk A and Carlsberg A.
Actieve functies van Grith Hagel
| Bedrijven | Functie | Begin |
|---|---|---|
| 2CUREX AB | Founder | 01-01-2006 |
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Founder | 07-04-2010 |
Eerdere bekende functies van Grith Hagel
| Bedrijven | Functie | Einde |
|---|---|---|
| CARLSBERG A/S | Corporate Officer/Principal | - |
| Noapab Holdings A/S | Founder | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| CARLSBERG A/S | Consumer Non-Durables |
| 2CUREX AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Noapab Holdings A/S | Commercial Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
